Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Kiwi, as of now, everyone gets reimbursement via TDAPA for CRMD. I forget the numbers, but it's a solid number. With the government picking up the costs for now, I expect a quick uptake.as it's an instant money maker for dialysis centers. The company expects to be around breakeven by year end, and that's without landing one of the two LDO's. At some point they may be put in the bundle. They are working on getting expanded label approval for cancer patients.
The one to watch is ARDX, which I know you were invested in. X sales grew over 100% q/q from $15M in the first quarter to $37M in only it's second quarter since launch. They turned down the government and won't accept being bundled. They have all the patient groups backing them and have filed a lawsuit against the government. There is also legislation in Congress, the Kidney PATIENT Act. All other legislation that has gone as far as their bill has gone on to become law as it has bipartisan support and was rated by the CBO to be a neutral cost to the government. I would rather sit tight holding that than holding AMRN, which I still have a position in, but a fraction of other holdings. They have Ibsrela to boot which is slated to be $1B seller in it's own right.
Do you still have PLTR? It's making new high's daily. I have also been moving towards stocks to do with satellites and space.
Yes rosemount...another of my biotechs where I have a good position. The potential for a bo is very real. At a minimum, they sound like they will quickly be making money.
Jas, as I told FFS earlier, look at other options. My biggest biotech holding is ARDX. Just had earnings. 2 drugs approved. Ibsrela had over 25% q/q revenue increase. Xphozah had over 100% q/q. Fantastic numbers! As solid a biotech as their is. Bright future with 2 drugs that will do over $1B each.
https://ir.ardelyx.com/news-releases/news-release-details/ardelyx-reports-second-quarter-2024-financial-results-and
Another one is PLTR. I mentioned it earlier today. Check out the earnings. This is a $1T dollar company in the making.
https://investors.palantir.com/news-details/2024/Palantir-Reports-Revenue-Growth-of-27-Year-Over-Year-and-Raises-Full-Year-Revenue-Guidance-Record-GAAP-EPS-of-0.06-in-Q2-2024
I am not saying to buy either stock. What I will say is you can and should be proactive to look at other options. I am very happy with my other investments, so I have no reason to lose sleep over AMRN. Once you move your focus on to other investments, you will feel so much better. Especially when the prospects are so much better. I personally feel buying down here is risky. At some point, if Denner adds big, or sales really move up in the EU, I may reconsider, but that could be 2 or 3 years from now. Good luck.
FFS, I have a small position. I don't believe it will ever be large again. I follow here to see where we are at. If anything, I have tried to get people to look at other options. Pretty much everything I am in has done better. That PLTR that we discussed a year ago, which is my biggest holding, has done well. Taking into account the earnings posted last week, everyone should be buying on any pullbacks. The future is in AI and they have the best software.
Fly, are you invested here? I don't post much because my position is small and I don't even bother to check often, but I see you tend to be here when I do, hence the question.
I sold 5000 shares at $.70. Still have too many shares. This is dead money for at least 6 months. BRAVE was a bust and no buy backs. Eventually it will be worth something, but I now expect that's over a year away. If my trades work, I will sell more. Moved into ARDX for earnings tomorrow. I will then roll into BCRX for Monday am and PLTR for Monday after the close. I wish I listened to HG when it was $4. Whatever you do, don't be foolish and put more money here when others have such better prospects. That cash position is already outdated. New multi year low on the horizon.
I believe you. I do wish you jumped into the conversation and asked them whom they worked for.
Very sad to hear about Jason. He was an icon on this board. Always ready to kick some ass! May he rest in peace!
I read from one of my other biotech holdings on Stocktwits.com...someone talked to a Bloomberg rep. They now have Institutional Drug Data and are waiting on Retail Data. It sounds like the wait may soon be over
cbb, even at cost, China could help AMRN increase cash significantly. The inventory is there and paid for. Lowering it by moving a chunk to China adds dollar for dollar to cash.
Does Novartis work?
In the end, supporting Denner will prove to be the right play. Those who have bashed him will be proven wrong. This really is a recovery story for 2024. If a sale is to happen, we should be looking at no sooner than 2025 to get a decent price. If the buyback is greenlit, double digits will follow at some point. No reason they can't increase and extend a buyback as sales grow worldwide. At least the stupid talk of bankruptcy or Denner taking the company private for $2 a share will stop.
jfm, my sincere condolences.
If it drops anywhere near 50%, I will be loading the boat for the uplist.
lol, I know...that's for the clowns that did. They know who they are.
What...I thought we were going bankrupt?
Before people have a heart attack, a shelf registration is something most biotech companies have. AMRN, if memory serves me correctly has had numerous ones over the years on a continuous basis. They expire after a few years, so they need to be renewed every so often. It doesn't necessarily mean any dilution is about to happen. I have had a few other companies I am invested in the last year renew a shelf. No dilution has happened yet, but it's like an insurance policy if they have a need for funds. With the capital markets being tight, it's no surprise that they would maintain one. Yeah, they might do something that benefits Denner, but it hasn't happened yet and may never happen.
Tat, yes it was factually incorrect and not a damn chance I am pissing off!
I explained it to you before. If you can't understand that. I can't help you.
FFS, did TA predict a ratings downgrade for US Sovereign Debt? Absolutely not!
FFS,
"OneRag was begging people to diversify into PLTR which got slapped today. LOL"
Down 5% is a slap down after a massive run? Your such an idiot! I wasn't begging anyone. Kiwi and I are both up over 100% this year. I bought it this year at $8.50 and have 6 digits invested. I am good! Anyone who buys it will make a ton of money a few years out. Whether anyone buys it, I could care less, but it is the leader in AI software, ahead of #2 Microsoft, #3 IBM, #4 AWS and #5 Google. They have earnings next week, if it drops I will double my position. If you did any research at all, you would know they have a 5 year lead on everyone else in this field. I am making a note of your mockery. I put it on my calendar to revisit PLTR's price in one year. Let's see who is laughing.
How is AMRN's bankruptcy going? Are you all in on the short? I mean you wouldn't try to hold anyone to a different standard than you yourself would follow...would you?
JRoon, I agree and was not saying it's a bad thing, but they paid the suppliers and didn't take the inventory is the end result. Ok, they altered supplier agreements. Are they done? Are there more adjustments? Losing $40M in inventory to gain $9M in cash isn't good business if it is a trend.
Called it last week. Inventory down over $40M. Ok, almost $10M in spoilage. That's the 2nd time in 2 years. Obviously someone needs to lose their job. The only thing that I can think of to account for the rest is they paid the suppliers but didn't take possession of any product. Any other ideas on where $30M in inventory went? Definitely took out the trash and are trying to prepare a path for a sale.
Fly, you keep proving how dumb you are. Why diversify? How about my PLTR has more than doubled in the last couple of months and is the leader in AI applications? If you are not invested, you should be. How about my CRMD?,..which I am green on, has a PDUFA coming in a few months that will probably be up at least 400% on approval. How about my ABML?,..which has the largest lithium deposits in North America, over $100M in govt grants and in the next 60 days will have their plant commissioned and producing black mass. My Arbor Realty which just raised it's dividend again, the 10th time in the last 11 quarters. Yes, that's quarters, not years. All these stocks as well as others I own that are doing well NOW!
I have total confidence in AMRN. I have publicly stated on this board I would not add. Why would I? I am doing fine while I wait. I am certain with your arrogance you have stocks that you have 100% conviction in but I am also certain you are not in it with all your assets. What a hypocrite!
Kiwi, exactly...I called him out on it and he vanished. I thought I saw his picture on a milk carton. Maybe he thinks AMRN has already filed for bankruptcy. Earnings have been much better than expected overall and the soft landing scenario is what's tracking. PLTR needs to crush it on earnings next week, or there will probably be a pullback, but it's on a great run. I will hold it for the longhaul. Hopefully others here are paying attention and diversifying their holdings. There are plenty of great stocks out there that the prospects are even better than AMRN's.
Canam, I hope you are correct. IMO, we lost money Q2. The question is how much? A "sale" on the share price could still be coming later this week.
jfm, I did buy ARDX, not ADRX. Thanks for the correction.
thanks Kiwi...I took a starter position in ADRX.
AMRN partners in Southeast Asia
https://amarincorp.com/news-and-media/amarin-and-lotus-pharmaceuticals-announce-exclusive-partnership
Thanks north.
Rosemount, have added a few thousand shares of BCRX earlier in the month to my holdings. I expect that with the revenue they are bringing in, we should be good to move up significantly. Institutional ownership over 90% with adds lately.
Jas, in the AI field my big position is Palantir(PLTR). The undisputed leader in data applications. Think about Microsoft before they were a giant. Kiwi and I are both invested. Like me, I am sure he is very happy with his position. I think of this like I did AMRN before the RI readout.
Dan Ives from Wedbush on CNBC yesterday talking about them.
Canam, because of the position he has, he must report any 1% change within a few days...positive or negative.
The dead cat bounce is over or so I was told yesterday Another "fact" that isn't a fact.
Tat, what I understand clearly is that you like Fly are all gloom and doom, but you are here. In the end, being here is a bigger tell than anything you post. Time will tell whose version of reality is correct. I will be here for that. So won't you!
Tatsumaki, this is without a doubt one of the most delusional posts I have read here. Just to be clear, his real basis is no where near $2. That like me setting up a separate entity and selling my $1 AMRN stock for $20 to my other entity and saying I made a ton of money. Fantasy is all that would be. Lowering a basis is not the same as making or losing money on the investment when you transpire with yourself. He paid around $4/ share. That's his investment. Now maybe he "sold" shares to another investment vehicle he owns. Maybe he "lost" money and has lowered his basis. Other than a tax break which he may have gotten, his money out of his pocket and invested in AMRN hasn't changed...Period! I am certainly not saying $15 is in the cards, but the gloom and doom is absolutely delusional. Diluted into oblivion...nows that's funny.
JRPac, I wanted to respond because you are correct. I jumped from buybacks to dividends inadvertently. It doesn't change the fact that buybacks use the same principle.
Key Aspects of a Share Buyback:
-This type of transaction is only used when the company is purchasing the shares from the shareholder and there is an exchange in money (nominal value at least).
-Shares can only be purchased by the company out of its distributable profits.
-Shares can be bought back at a premium.
-This process requires a special resolution.
When bought back, the shares are either cancelled or held as treasury shares.
Covered by Companies Act 2014 and Taxes Consolidation Act 1997.
TCI1, my post to Invest yesterday was that AMRN could not issue any dividends unless from profits which they don't have based on Irish law. Having the parent company be English doesn't change the fact they cannot issue dividends unless they have distributable profits. I wish that wasn't the case, but until they start making money consistently, their will be no dividends. You interjected and more than implied dividends could be paid. Another poster actually got in on the conversation and agreed with you that dividends could be paid. I didn't see you correct the other poster they couldn't. At this point, I am going to leave the conversation here. I am not here to bicker with others. We all have the same goal. I have been here over a decade and rarely post anymore because I don't have the time. I have wasted enough here. Here's to hoping for a BO within 18 months. Have a great day.
TCI1,
https://www.sec.gov/ix?doc=/Archives/edgar/data/897448/000095017023005336/amrn-20221231.htm
Dividends page 65
We have never paid dividends on our ordinary shares and do not anticipate paying any cash dividends on our ordinary shares in the foreseeable future. Under English law, any payment of dividends would be subject to relevant legislation and our Articles of Association, which requires that all dividends must be approved by our board of directors and, in some cases, our shareholders, and may only be paid from our distributable profits available for the purpose, determined on an unconsolidated basis.
JRPac, from that same 10k you posted. There is no listing of an office in England, which is a requirement of jurisdiction, but that's irrelevant. Go down to dividends and it clearly states dividends can only be paid by distributable profits. You can go back to your post and see it on page 65. I posted the relevant section below. Please note the highlighted line.
The following table lists the location, use and ownership interest of our principal properties as of March 1, 2023:
On September 13, 2022, we entered into a License Agreement for office space in Dublin, Ireland effective October 1, 2022 which terminates on September 30, 2024 and can be extended automatically for successive two year periods.
Effective February 5, 2019, we entered into a lease agreement for approximately 67,747 square feet of office space in Bridgewater, New Jersey. The lease commenced on August 15, 2019, for an 11-year period, with two five-year renewal options. On January 20, 2023, we entered into a sublease agreement to sublease 50,000 square feet of the leased 67,747 square feet of office space in Bridgewater, New Jersey. The sublease commences on February 1, 2023 and terminates as of the date of the head lease.
On October 10, 2021, we entered into a lease agreement for approximately 4,511 square feet of office space in Zug, Switzerland. The lease commenced on February 1, 2022 for a 5-year period, with one five-year renewal option.
Dividends page 65
We have never paid dividends on our ordinary shares and do not anticipate paying any cash dividends on our ordinary shares in the foreseeable future. Under English law, any payment of dividends would be subject to relevant legislation and our Articles of Association, which requires that all dividends must be approved by our board of directors and, in some cases, our shareholders, and may only be paid from our distributable profits available for the purpose, determined on an unconsolidated basis.
Kaiser is both the hospital and insurer?...correct? All those surgeries and care that was postponed due to covid are in catch up mode as reported by United Health last week. The stock was down on that news. I am sure they are not the only one.